Adding sotatercept to standard therapy within a year of diagnosis lowers the risk for clinical worsening in patients with pulmonary arterial hypertension at an intermediate or high risk for death.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/sotatercept-may-benefit-early-pulmonary-arterial-2025a1000sif?src=rss
Author :
Publish date : 2025-10-21 11:04:00
Copyright for syndicated content belongs to the linked Source.
